Exhibit 99.1
 | Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com |
November 4, 2024
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Ltd. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company at its meeting held on November 4, 2024, has approved the grant of stock options to the eligible employees under the Employees Stock Option Schemes of the Company:
| Sl. No. | Type of Option(s) | Number of options granted | Value | Exercise Price per share | ESOP Scheme |
| 1 | Indian Stock Options | *4,820 | Fair Market Value | Rs. 1,274/- | Dr. Reddy’s Employees Stock Option Scheme, 2018 |
| * | Equally graded vesting in 4 years. |
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K. Randhir Singh
Company Secretary, Compliance Officer & Head-CSR